sorafenib has been researched along with bafilomycin a1 in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (bafilomycin a1) | Trials (bafilomycin a1) | Recent Studies (post-2010) (bafilomycin a1) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,120 | 1 | 484 |
| Protein | Taxonomy | sorafenib (IC50) | bafilomycin a1 (IC50) |
|---|---|---|---|
| P2X purinoceptor 3 | Homo sapiens (human) | 0.755 | |
| V-type proton ATPase subunit S1 | Homo sapiens (human) | 0.1 | |
| Vacuolar proton pump subunit B | Gallus gallus (chicken) | 0.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graham, RM; Thompson, JW; Webster, KA | 1 |
| Kang, R; Liu, J; Tang, D; Wen, Q; Zhou, B | 1 |
2 other study(ies) available for sorafenib and bafilomycin a1
| Article | Year |
|---|---|
Inhibition of the vacuolar ATPase induces Bnip3-dependent death of cancer cells and a reduction in tumor burden and metastasis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Butadienes; Cell Hypoxia; Enzyme Inhibitors; Gene Knockdown Techniques; Heterografts; Humans; Hydrogen-Ion Concentration; Macrolides; MAP Kinase Signaling System; MCF-7 Cells; Membrane Proteins; Mice; Neoplasm Metastasis; Niacinamide; Nitriles; Phenylurea Compounds; Proto-Oncogene Proteins; Sorafenib; Tumor Burden; Vacuolar Proton-Translocating ATPases | 2014 |
The release and activity of HMGB1 in ferroptosis.
Topics: Animals; Autophagy; Carbolines; Cell Death; Cell Line, Tumor; Chloroquine; Ferritins; Fibroblasts; HMGB1 Protein; Humans; Immunity, Innate; Inflammation; Iron Overload; Lipid Peroxidation; Macrolides; Mice; Neoplasms; Oximes; Piperazines; Sorafenib; Sulfonamides; Toll-Like Receptor 4 | 2019 |